Brickwork Ratings revises the ratings for the Bank Loan Facilities of Rs. 300.00 Crs. of HIL (India) Ltd. (erstwhile Hindustan Insecticides Ltd.)
ParticularsFacilities** | Amount (Rs.Crs.) | Tenure | Rating# | ||
---|---|---|---|---|---|
Previous | Present | Previous (11 Aug 2021) |
Present | ||
Fund Based | 250.00 | 250.00 | Long Term |
BWR D
Downgrade |
BWR BB
/Stable Upgrade |
Non Fund Based | 50.00 | 50.00 | Short Term |
BWR D
Downgrade |
BWR A4
Upgrade |
Grand Total | 300.00 | 300.00 | (Rupees Three Hundred Zero Crores Only) |
Brickwork ratings has upgraded the Long Term rating to BWR BB, with a ‘Stable’ outlook and short term rating to BWR A4, of HIL (India) Ltd (referred to as ‘HIL’ or ‘the company’), from BWR D/ D, as the company has been regular in servicing of its debt obligation for the last six months. Furthermore, the ratings derives strength from the company’s position as a Government of India enterprise, its established position as the sole public sector enterprise in India for the manufacturing of Dichlorodiphenyltrichloroethane (DDT), pesticides and agro chemicals, etc., and diversified product mix & geographical presence of the company. The ratings are, however, constrained by the weak financial risk profile, competition from various players and delays in realization of receivables from the customers.
Outlook: Stable
BWR believes that the business and financial risk profile of HIL will be maintained over the medium term. The ‘Stable’ outlook indicates a low likelihood of rating change over the medium term. The outlook may be revised to 'Positive' in case revenue and profitability show a sustained improvement leading to an improved financial and liquidity profile. The rating outlook may be revised to 'Negative' in case the profitability generated is much lower than anticipated, or there is a significant deterioration in the overall liquidity profile of the company.
Credit Strengths:
The company has been regular in servicing of its debt obligation since August-2021. The same has also been confirmed by the lender of the company.
HIL, formerly known as Hindustan Insecticide Limited, is a Government of India Enterprise incorporated in the year 1954. HIL is the only manufacturer of Dichlorodiphenyltrichloroethane (DDT) and also the only central public sector enterprises (CPSE) operating in Public Health and Crop Protection segments in India. The Company is one of the five national level seed agencies in India and derives a significant part of its sales from state governments.
HIL is the primary and sole supplier of DDT to the National Vector Borne Disease Control Programme of the Ministry of Health. The company gradually diversified into agrochemicals and is presently the sole public sector enterprise in the pesticides field. The product range of the company includes Insecticides, Herbicides, Weedicides and Fungicides etc.The company also exports its agro products to Netherlands, UK, Jamaica, UAE, Manila, South Korea, Belgium, Guatemala, France, Germany, Argentina, Ethiopia, Egypt, Spain, etc. and its products are well-accepted internationally. HIL has reputed clientele viz., Ministry of Chemicals & Fertilizers, Ministry of Health & Family Welfare, Ministry of Agriculture, Steel Authority of India Limited, Indian Oil Corporation, Bharat Electronics Limited., Coal India Limited, Haryana Tourism etc. The Company majorly supplies its products to MoHFW (Ministry of Health and family welfare) and various state governments.
The company has reported a decline of ~3% in its operating income in FY21 (from Rs.394.09 crs in FY20 to Rs. 382.19 crs in FY21) due to reduction in orders of DDT from the Ministry of health and family welfare in Q1FY21. The capital structure (Total debt/ Tangible Networth) of the company also deteriorated from 1.50x, as on March 31, 2020 to 1.97x, as on March 31, 2021, on account of availment of new term loans. The interest service coverage ratio of the company also stood weak (at below unity) in FY21. Insufficient profitability had resulted in cash flow mismatches in the past which led to delays in the servicing of the bank debt obligation. However, the banking conduct of the company has remained satisfactory, with no delays reported since Aug-2021.
The agrochemical industry is considered to be highly competitive due to the presence of many small & large private players. The company faces high competition from a large number of players in both organized and unorganized sectors in Pesticides, Fertilisers, etc.
Historically, the average collection period of the company has remained high and the same stood at 379 days, as on March 31, 2021 (Previous year: 358 days). Since the company sells its products majorly to Government bodies and State governments, it receives the payments from these entities with a delay.
HIL has availed a term loan from the Government of India for which the outstanding amount (including interest) stood at Rs.79.86 Crs, as on March 31, 2021. The same was availed against the receivables from the MOHFW (Ministry of Health and Family welfare). However, owing to delay in realization of these debtors (Rs.99 Cr., as on March 31, 2021), HIL has not been able to repay the term loan to the GoI and has requested the Government to adjust the same with the receivables from MOHFW.
For arriving at its ratings, BWR has applied its rating methodology as debited in the Rating Criteria detailed below ( hyperlinks provided at the end of this rationale).
RATING SENSITIVITIES
Positive: The rating may be upgraded in case the revenues and profit show sustained improvement backed by healthy liquidity.
Negative: The rating may be downgraded in case revenues of the company substantially deteriorates from the current level. Rating may also be adversely affected in case of deterioration in gearing, coverage ratios, liquidity profile and delay in receipt of funds from the land deals.
LIQUIDITY INDICATORS - Stretched
The operating cycle of the company has remained elongated historically and the same stood at 259 days, as on March 31, 2021 (PY: 234 days), owing to high average collection and average inventory holding days. Due to covid - 19, the company had faced issues in the realization of payment from the Ministry of Chemicals and Fertilizers, resulting in delays in debt servicing till July-2021. However, there were no instances of over utilization in the cash credit facility and no delays were observed in the servicing of debt obligation in the term loan and GECL facilities, in the last six months i.e from Aug 2021. A DSRA of Rs.15 cr. has also been maintained by the company at the bank which provides a liquidity cushion. The fund-based working capital facility of Rs.150 Cr., remained ~83% utilized, on an average, in the six month period from Aug-2021 to Jan-2022. The Company had achieved cash accruals of Rs 6.46 Crs in FY 21 which improved slightly from Rs. 6.13 Cr in FY20. The company has a repayment obligation of ~Rs.23 Cr. in FY22 and ~Rs.35 Cr. in FY23, which is projected to be met through the cash accruals and proceeds expected from the sale of land. HIL has sold a parcel of land admeasuring 4.60 acres to Haryana Shahari Vikas Pradhikaran (formerly HUDA), for widening of highway. Against the total consideration of Rs.80 Cr. to be paid to HIL, the company has received Rs. 21 Crs. in the current financial year (so far) and is expected to receive Rs.16 Crs by the end of the financial year FY22. The remaining amount (Rs. 43 Cr.) is expected to be received in FY23. The same is expected to support the liquidity profile of the company. Also, the company has entered into an agreement with NBCC (India) Ltd to develop a vacant land situated at Zakhira, New Delhi having total area of 5.12 acre which is expected to be completed in the next 3 years. The successful development and sale of the land will provide additional cash flows to HIL. However, timely receipt of cash flows from the sale of these land parcels shall remain a key rating sensitivity going forward. HIL is also carrying out capex in various product lines to further expand its product portfolio. These projects are being majorly funded through the financial support from the GoI in the form of grants.
ABOUT THE ENTITYHIL (INDIA) LTD formerly known as Hindustan Insecticide Limited is a Government of India Enterprise. The Company is under the administrative control of the Department of Chemicals and Petrochemicals, under Ministry of Chemicals and Fertilizers. HIL is the only manufacturer of Dichlorodiphenyltrichloroethane (DDT) and also the only central public sector enterprises (CPSE) operating in the Public Health and Crop Protection segments in India. The company has gradually diversified into agrochemicals and is presently the sole public sector enterprise in the pesticides field. The product range of the company includes Insecticides, Herbicides, Weedicides and Fungicides etc. The Company has three manufacturing units in Rasayani (Maharashtra), Udyogamandal (Kerala) and Bhatinda (Punjab). The company exports its agro-products to Netherlands, UK, Jamaica, UAE, Manila, South Korea, Belgium, Guatemala, France, Germany, Argentina, Ethiopia, Egypt, Spain, etc. and its products are well-accepted internationally. HIL has a reputed clientele viz., Ministry of Chemicals & Fertilizers, Ministry of Health & Family Welfare, Ministry of Agriculture, Steel Authority of India Limited, Indian Oil Corporation, Bharat Electronics Limited., Coal India Limited, Haryana Tourism etc.
KEY FINANCIAL INDICATORS (Standalone)Key Parameters | Units |
FY 20-21 (Audited) |
FY 19-20 (Audited) |
---|---|---|---|
Operating Revenue | Rs.Crs. | 382.19 | 394.09 |
EBITDA | Rs.Crs. | 12.55 | -6.42 |
PAT | Rs.Crs. | 1.15 | 0.59 |
Tangible Net Worth | Rs.Crs. | 108.31 | 108.10 |
Total Debt/Tangible Net Worth | Times | 1.97 | 1.50 |
Current Ratio | Times | 1.39 | 1.22 |
Facilities | Current Rating (2022) | 2021 | 2020 | 2019 | |||||
---|---|---|---|---|---|---|---|---|---|
Type | Tenure | Amount (Rs.Crs.) |
Rating | Date | Rating | Date | Rating | Date | Rating |
Fund Based | LT | 250.00 |
BWR BB/Stable
(Upgrade) |
11Aug2021 |
BWR D
(Downgrade) |
11May2020 |
BWR BBB-Stable
(Upgrade) |
20Sep2019 |
BWR BB+Stable
(Downgrade/ISSUER NOT COOPERATING*) |
Non Fund Based | ST | 50.00 |
BWR A4
(Upgrade) |
11Aug2021 |
BWR D
(Downgrade) |
11May2020 |
BWR A3
(Upgrade) |
20Sep2019 |
BWR A4+
(Downgrade/ISSUER NOT COOPERATING*) |
Grand Total | 300.00 | (Rupees Three Hundred Zero Crores Only) |
BWR complexity levels are meant for educating investors. The BWR complexity levels are available at www.brickworkratings.com / download / ComplexityLevels.pdf. Investors queries can be sent to info@brickworkratings.com.
Hyperlink/Reference to applicable CriteriaAnalytical Contacts | |
---|---|
Neha Wahi Ratings Analyst Board : +91 11 2341 2232 nehawahi@brickworkratings.com |
Sudeep Sanwal Associate Director - Ratings sudeep.s@brickworkratings.com |
1-860-425-2742 | media@brickworkratings.com |
SL.No. | Name of the Bank/Lender | Type Of Facilities | Long Term(Rs.Crs.) | Short Term(Rs.Crs.) | Total(Rs.Crs.) | |
---|---|---|---|---|---|---|
1 | Union Bank of India | Term LoanSanctioned | 100.00 | _ | 100.00 | |
2 | Union Bank of India | Cash CreditSanctioned | 150.00 | _ | 150.00 | |
3 | Union Bank of India | Letter of CreditSanctioned | _ | 50.00 | 50.00 | |
Total | 250.00 | 50.00 | 300.00 | |||
TOTAL (Rupees Three Hundred Zero Crores Only) |
The Rating Rationale is sent to you for the sole purpose of dissemination through your print, digital or electronic media. While it may be used by you acknowledging credit to BWR, please do not change the wordings in the rationale to avoid conveying a meaning different from what was intended by BWR. BWR alone has the sole right of sharing (both direct and indirect) its rationales for consideration or otherwise through any print or electronic or digital media.
About Brickwork RatingsBrickwork Ratings (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by Reserve Bank of India [RBI], offers credit ratings of Bank Loan, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. BWR has rated over 11,400 medium and large corporates and financial institutions’ instruments. BWR has also rated NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations. BWR has Canara Bank, a leading public sector bank, as one of the promoters and strategic partner. BWR has its corporate office in Bengaluru and a country-wide presence with its offices in Ahmedabad, Chandigarh, Chennai, Hyderabad, Kolkata, Mumbai and New Delhi along with representatives in 150+ locations.
Disclaimer
Brickwork Ratings India Pvt. Ltd. (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by the Reserve Bank of India [RBI], offers credit ratings of Bank Loan facilities, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. [ hereafter referred to as "Instruments"]. BWR also rates NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations.
BWR wishes to inform all persons who may come across Rating Rationales and Rating Reports provided by BWR that the ratings assigned by BWR are based on information obtained from the issuer of the instrument and other reliable sources, which in BWR"s best judgment are considered reliable. The Rating Rationale / Rating Report & other rating communications are intended for the jurisdiction of India only. The reports should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in Europe and also the USA).
BWR also wishes to inform that access or use of the said documents does not create a client relationship between the user and BWR.
The ratings assigned by BWR are only an expression of BWR"s opinion on the entity / instrument and should not in any manner be construed as being a recommendation to either, purchase, hold or sell the instrument.
BWR also wishes to abundantly clarify that these ratings are not to be considered as an investment advice in any jurisdiction nor are they to be used as a basis for or as an alternative to independent financial advice and judgment obtained from the user"s financial advisors. BWR shall not be liable to any losses incurred by the users of these Rating Rationales, Rating Reports or its contents. BWR reserves the right to vary, modify, suspend or withdraw the ratings at any time without assigning reasons for the same.
BWR"s ratings reflect BWR"s opinion on the day the ratings are published and are not reflective of factual circumstances that may have arisen on a later date. BWR is not obliged to update its opinion based on any public notification, in any form or format although BWR may disseminate its opinion and analysis when deemed fit.
Neither BWR nor its affiliates, third party providers, as well as the directors, officers, shareholders, employees or agents (collectively, "BWR Party") guarantee the accuracy, completeness or adequacy of the Ratings, and no BWR Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Rating Rationales or Rating Reports. Each BWR Party disclaims all express or implied warranties, including, but not limited to, any warranties of merchantability, suitability or fitness for a particular purpose or use. In no event shall any BWR Party be liable to any one for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Rating Rationales and/or Rating Reports even if advised of the possibility of such damages. However, BWR or its associates may have other commercial transactions with the company/entity. BWR and its affiliates do not act as a fiduciary.
BWR keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of BWR may have information that is not available to other BWR business units. BWR has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.
BWR clarifies that it may have been paid a fee by the issuers or underwriters of the instruments, facilities, securities etc., or from obligors. BWR"s public ratings and analysis are made available on its web site, www.brickworkratings.com. More detailed information may be provided for a fee. BWR"s rating criteria are also generally made available without charge on BWR"s website.
This disclaimer forms an integral part of the Ratings Rationales / Rating Reports or other press releases, advisories, communications issued by BWR and circulation of the ratings without this disclaimer is prohibited.
BWR is bound by the Code of Conduct for Credit Rating Agencies issued by the Securities and Exchange Board of India and is governed by the applicable regulations issued by the Securities and Exchange Board of India as amended from time to time.